Dysfunction of the intestinal epithelium barrier (DIEB) is frequent and can lead to serious complications in early childhood when diagnosis and clinical intervention are limited, especially in ...

State Rep. Samara Heavrin, R-Leitchfield, presented before the Interim Joint Committee on Banking and Insurance last week on proposed legislation that would require health plans to expand coverage for ...

WASHINGTON — President Trump urged pregnant women Monday to stop taking Tylenol, saying studies have shown that taking the common painkiller is associated with autism in children. “With Tylenol, don’t ...

As President Trump and Health Secretary Robert F. Kennedy Jr. prepared to announce that they believe the use of acetaminophen — the active ingredient in Tylenol — by pregnant women may be linked to ...

President Donald Trump announced that taking the common pain relief drug Tylenol during pregnancy can lead to an increased risk of autism for unborn babies, due to the drug's active ingredient ...

President Donald Trump on Monday linked autism in children to the use of Tylenol during pregnancy, blaming the drug’s use for increased autism rates nationwide.

Trump: FDA will tell doctors pregnant women should limit acetaminophen use to lower chances of autism diagnosis in children President Donald Trump makes an announcement regarding acetaminophen usage ...

Nicole Charky-Chami is a senior editor based in Los Angeles, writing and producing breaking news. She teaches journalism courses for UCLA Extension and previously taught at Loyola Marymount University ...

WASHINGTON ‒ President Donald Trump urgently warned pregnant women to avoid taking Tylenol as he promoted an unproven link between the painkiller and a rise in autism among children. “Don’t take ...

Sept. 22 (UPI) --Meta announced Monday it is partnering with the U.S. General Services Administration on an initiative that will give the government access to its Llama open source AI models. The ...

Leucovorin brings hope as the first potential autism treatment, but with RFK Jr. weighing whether to fast-track approval, scientists worry about trust. When Nathaniel Schumann entered the clinical ...